Laparoscopic Transvaginal Hybrid Anterior Resection: a Prospective Data Collection
- Conditions
- Sigmoid Diverticulitis (Hinchey I and II)Sigmoid Diverticulosis With Two or More Attacks of Diverticulitis
- Interventions
- Procedure: Laparoscopic transvaginal hybrid anterior resection
- Registration Number
- NCT01043731
- Lead Sponsor
- Cantonal Hospital of St. Gallen
- Brief Summary
Transvaginal hybrid procedures are of interest as an available NOTES-Procedure for the clinical routine. Few authors have demonstrated the feasibility and safety of such procedures (e.g. cholecystectomy) in selected patient collectives. In 2008 Lacy at al. published the experience with a transvaginal sigmoidectomy as a first in human report. The aim of this prospective data collection is to evaluate the feasibility and safety of the transvaginal hybrid anterior resection in the clinical routine.
Therefore all patients giving the informed consent to the transvaginal hybrid anterior resection will be included and assessed concerning feasibility to perform the transvaginal approach and complete the operation transvaginally.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 45
- given informed consent
- sigmoid diverticulosis (two or more attacks)
- sigmoid diverticulitis (Hinchey I and II)
- ASA IV
- emergency surgery
- liver-malfunction or coagulation disorders
- acute diverticulitis (Hinchey III and IV)
- malignancy
- acute vaginal infection
- refusal of mandatory preoperative gynecological examination
- pregnancy
- endometriosis
- previous surgery of colon and rectum
- strongly retroflexed uterus
- acute pelvic disorders, infection
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Ginven indication for laparoscopic anterior resection Laparoscopic transvaginal hybrid anterior resection -
- Primary Outcome Measures
Name Time Method Feasibility and safety of the transvaginal operation 30 days
- Secondary Outcome Measures
Name Time Method Long-term life quality and sexual dysfunction 3 year
Trial Locations
- Locations (1)
Department of surgery
🇨ðŸ‡St. Gallen, Switzerland